Over 150 Missouri Auctions End Tomorrow 06/05 - Bid Now

Cecilia Danckwardt-Lillieström

C-RAD appoints new CFO
August 28, 2018
Rad Oncology Radiation Therapy
C-RAD today announces that Cecilia Danckwardt-Lillieström has been appointed Chief Financial Officer effective October 15, 2018, succeeding Therése Björklund who will assume another position within the finance department at the company.

Cecilia has an extensive experience and has held several leading positions within finance. She is currently a Senior Manager & Head of the Uppsala office for the financial audit and consulting firm KPMG, a position she has held for 3 years. Prior to that, she held the position as CFO for Fastum UBC Förvaltning AB. She has also worked for RaySearch Laboratories AB as CFO, as Director of Finance for MySQL AB, for Biotage AB (publ) as Group controller and for PwC as Senior Manager. Cecilia holds a master’s degree in business and Economics from the Uppsala University.

Therése decided to step down from the position as CFO for personal reasons.
stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.

stats
“Cecilia´s very broad financial experience will be a great asset for C-RAD supporting the growing organization. I am very much looking forward to work with Cecilia as our CFO and I am confident that she will be a strong addition to the management team of C-RAD.” says Tim Thurn, CEO C-RAD AB

“I am really looking forward to join the management team of C-RAD. I will certainly do my best to contribute in the continuing development of the finance strategy as well as the future growth of C-RAD”, says Cecilia Danckwardt-Lillieström.

“I want to take the opportunity to thank Therése for the excellent work and the support during the past two years. As a member of the management team she has made an important contribution to build up the organization and finance department in a period a significant growth. I very much welcome her decision to stay in the organization after her change.” says Tim Thurn, CEO C-RAD AB.


About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

You Must Be Logged In To Post A Comment

advertisement

 

classifieds

Rad Oncology Homepage

Olympus to acquire BioProtect in $270 million deal focused on prostate cancer care
Balloon Spacer creates temporary space between prostate and nearby organs during radiation therapy
Philips launches 4D MR imaging tool for radiotherapy simulation
Combines respiratory motion-resolved 4D MRI with multiple image contrasts in a single free-breathing workflow
Dana-Farber to add Mevion proton therapy system at Boston campus
MEVION S250-FIT is designed to fit into existing linear accelerator vaults
Iridium completes first online adaptive treatment on Varian TrueBeam using RaySearch software
OART allows clinicians to modify treatment plans during a patient’s treatment session
Siemens Healthineers to receive up to $83 million in funding to develop photon flash radiotherapy
Project will focus on adapting photon-based Flash therapy for use on conventional linear accelerators
Radiation oncologists warn Medicare changes threaten community cancer clinics
ASTRO urges Congress to pass the Radiation Oncology Case Rate (ROCR) Act
ASRT survey finds modest decline in radiation therapy vacancies
Average number of full-time equivalent radiation therapists per facility also decreased slightly
Oregon health center opens $650 million facility to expand cancer care capacity
The Vista Pavilion is expected to increase OHSU Hospital’s capacity by roughly one-third
Louisiana hospital opens $3 million interventional radiology suite
Rapides Regional Medical Center expands access to interventional oncology, vascular and musculoskeletal treatments
How AI-driven functional precision medicine unlocks personalized cancer therapy
Insights from Jim Foote, CEO and cofounder at First Ascent Biomedical